Spotlight Innovation Inc. (OTCMKTS:STLT) Files An 8-K Other Events
Item 8.01 Other Events.
On June 30, 2017, Spotlight Innovation Inc. issued a Press
Release announcing that it has engaged PCG Advisory Group as its
investor relations firm. A copy of this Press Release is
furnished as Exhibit 99.1 hereto and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit
The following document is furnished as an Exhibit to Item 8.01
hereof:
|
Exhibit |
|
| 99.1 |
Press Release dated June 30, 2017. |
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
SPOTLIGHT INNOVATION INC. |
||
|
Dated: June 30, 2017 |
By: |
/s/ John William Pim |
|
John William Pim |
||
|
Chief Financial Officer |
||
EXHIBIT INDEX
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit
The following document is furnished as an Exhibit
Spotlight Innovation Inc. ExhibitEX-99.1 2 stlt_ex991.htm PRESS RELEASE stlt_ex991.htmEXHIBIT 99.1 Spotlight Innovation Engages Investor Relations Firm PCG Advisory Group URBANDALE,…To view the full exhibit click here About Spotlight Innovation Inc. (OTCMKTS:STLT)
Spotlight Innovation Inc., formerly American Exploration Corporation, is a bioscience company. The Company is focused on acquiring the rights, through acquisition, license or otherwise, to various technologies. The Company is engaged in identifying and targeting technology candidates, including cancer drugs and treatment therapies for various disease states; drug and related treatment therapies for various infectious diseases, and other technology candidates. The Company focuses on diseases that are rare, which are known as orphan diseases, or new or common but underserved, such as feline chronic kidney disease. As of December 31, 2015, the Company had three subsidiaries: Celtic Biotech Iowa, Inc., CDT Veterinary Therapeutics, Inc. and Memcine Pharmaceuticals, Inc. Through its subsidiary, Celtic Biotech Iowa, Inc., it develops a range of drug candidates, such as Crotoxin, Cardiotoxin, VRCTC310 and Crotamine. Through its subsidiary, Memcine Pharmaceuticals, Inc., it offers Immunoplex.
